Credit: Unsplash/CC0 Public Domain Rates of prostate cancer across Europe since 1980 are “indicative of overdiagnosis,” say researchers in a study published by The BMJ. Overdiagnosis refers to the detection of harmless cancers that are unlikely to cause symptoms or death during a patient’s lifetime, which can lead to unnecessary treatment, negative impacts on quality